Quantcast

Latest Off-label use Stories

2011-08-31 13:40:00

With so few FDA indicated medications for treating alcohol detox, top addiction professionals are forced to prescribe â˜off labelâ options, which can ultimately be used against the prescribing physicians by malpractice attorneys attempting to discredit doctors. Malibu, California (PRWEB) August 31, 2011 Dr. Akikur Mohammad, Founder of Malibu Horizon, one of the best rehab centers for alcohol treatment and alcohol detox in the country and Assistant...

2011-06-13 15:50:15

Accurate, safe prescribing information for children is often unavailable to doctors in Canada because pharmaceutical companies will not disclose information to Health Canada, states an editorial in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj110563.pdf Health professionals in Canada as well as other countries such as Japan and Australia, unlike their colleagues in the United States and Europe, do not have access to the same body of...

2011-05-11 06:00:00

BAYSIDE, N.Y. and GERMANTOWN, Md., May 11, 2011 /PRNewswire-USNewswire/ -- The national Tourette Syndrome Association (TSA) and Psyadon Pharmaceuticals Inc. are pleased to announce their collaboration on a clinical trial to determine the potential efficacy of a novel drug, ecopipam, for managing the symptoms of the neurological disorder Tourette Syndrome (TS). "This is the first time in our 39-year history that TSA has collaborated with the pharmaceutical industry and helped to fund a...

2011-04-21 07:52:13

(Ivanhoe Newswire) -- Physicians may be misusing and overusing an expensive blood clotting drug, and the practice could be dangerous for patients. The drug known as recombinant factor 7a (RF7a) is intended for hemophilia patients, but a pair of new studies found it's being used predominantly to treat patients who don't have the disorder. Hemophilia is a rare bleeding disorder in which the blood doesn't clot normally. Studies from the Stanford University School of Medicine estimated that only...

2011-04-06 11:20:36

Despite Federal Drug Administration regulation of the approval and use of pharmaceutical products, "off-label" marketing of drugs (for purposes other than those for which the drug was approved) has occurred in all aspects of the US health care system. In a study published in this week's PLoS Medicine, Aaron S. Kesselheim from Brigham and Women's Hospital, Boston, USA and colleagues report that the most common alleged off-label marketing practices also appear to be the most difficult to...

2011-03-06 00:02:31

DoctorDirectory, a leading market services company serving healthcare professionals and pharmaceutical industry clients, surveyed practicing physicians in the US to assess physician attitudes on the FDA's Bad Ad Program. Asheville, NC (Vocus/PRWEB) March 04, 2011 In May, 2010 The US Food and Drug Administration launched a program designed to educate healthcare providers (HCPs) and enlist them in helping the agency spot misleading prescription drug information. The initiative, known as the...

2011-01-13 18:23:27

Medical ethicists examine aggressive marketing tactics' influence on medical practice and outline strategies to protect patients Drugs that pharmaceutical companies market most aggressively to physicians and patients tend to offer less benefit and more harm to most patients "” a phenomenon described as the "inverse benefit law" in a paper from the University of Texas Medical Branch at Galveston. Published online Thursday, Jan. 13 in the American Journal of Public Health, the article...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related